In conclusion, EMAP II not only exerts antitumor effects by inducing autophagy of tumor cells, inhibiting angiogenesis, sensitizing tumor cells to TNF-α, and increasing the permeability of BTB, but also promotes the development of cancer by inducing lymphocyte apoptosis (Fig. 3). Here, AIMP1 is linked to cancer.